Michael Vrana, MD
Orthopaedic Surgery · New Braunfels, TXNPI 1164602868
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,892 of the $9,232 with a category attached, or 63.8%. Smith+Nephew accounts for 89.4% of it on its own, with 10 other manufacturers making up the rest.
Across 47 payments — averaging $196.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Esaote North America, Inc.$294
- Medtronic$215
- Pacira Pharmaceuticals Incorporated$189
- Stryker$79
- SPR Therapeutics, Inc$78
- plus $120 from 5 others
What the payments were for
- Travel & lodging$5,89264%
- Food & beverage$3,04633%
- Ownership interest$2943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 31 | $8,257 |
| Esaote North America, Inc. | 1 | $294 |
| Medtronic | 2 | $215 |
| Pacira Pharmaceuticals Incorporated | 4 | $189 |
| Stryker | 2 | $79 |
| SPR Therapeutics, Inc | 1 | $78 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Abbott | 1 | $24 |
| Bioventus LLC | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RI.HIP NAVIGATION$4,890
- Journey II$4,835
- JOURNEY$4,637
- OR3O Dual Mobility$3,565
- REAL INTELLIGENCE$3,210
- Legion Revision$2,790
- Tandem$2,376
- POLARSTEM$2,343
- REDAPT$1,639
- VISIONAIRE$336
- SC3421 Convex Probe$294
- Anthology$252
- KYPHON EXPRESS II KYPHOPAK TRAY$131
- EXPAREL$118
How this compares
$9,232 in reported general payments places this provider in the 65th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 201 | $2,137 |
| Naproxen | 175 | $1,052 |
| Methylprednisolone | 48 | $296 |
| Tramadol Hcl | 23 | $57 |
| Amoxicillin | 34 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Braunfels
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.